Αποτελέσματα Αναζήτησης
25 Ιουν 2020 · This ESMO Clinical Practice Guideline provides key recommendations on the management of prostate cancer. •. Authorship includes a multidisciplinary group of experts from different institutions and countries in Europe. •. Key treatment recommendations are provided. •. Recommendations have been updated in the light of new evidence. Key words.
7 Νοε 2020 · Evidence synthesis. A risk-adapted strategy for identifying men who may develop PCa is advised, generally commencing at 50 yr of age and based on individualised life expectancy.
21 Μαρ 2023 · Clinical Practice Guideline. darolutamide. Lu-PSMA. prostate cancer. The following ESMO Clinical Practice Guideline has been recently updated with new treatment recommendations: Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 1. eUPDATE.
For prostate cancer, radical prostatectomy remains the gold standard for surgical management. Given the side effects associated with surgery, patients at low risk of prostate cancer-specific mortality should consider active surveillance under the guidance of a urologist to safely delay intervention. For patients with an intermediate risk of ...
The risk of clinically significant prostate cancer is related to age, ethnicity, family history, PSA level, free/total PSA ratio and findings on digital rectal examination (DRE) . High-grade prostate cancer can occur in men with a ‘normal’ PSA level.
15 Δεκ 2021 · 1.1.1. For advice on communication and patient-centred care throughout the patient journey, follow the recommendations in the NICE guidelines on improving outcomes in urological cancers and improving supportive and palliative care for adults with cancer. [2008] 1.1.2. Offer people with prostate cancer information tailored to their own needs.
Recommended provided there are no contra-indications (Grade A) TAP block. Recommended for laparoscopic/robotic procedures (Grade A) Wound infiltration. Recommended for open surgery (Grade B) COX, cyclooxygenase; NSAID, non-steroidal anti-inflammatory drug; TAP, transversus abdominis plane. PROSPECT publication.
